Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
CYSTOGRAFIN DILUTE is a dilute solution of diatrizoate meglumine, a water-soluble iodinated contrast agent administered via urethral route for diagnostic imaging of the urinary tract. It is used in cystography and other urological imaging procedures to visualize bladder and urethral anatomy. The agent works by attenuating X-rays, enabling radiographic visualization of urinary structures.
As a legacy diagnostic agent approaching loss of exclusivity with moderate competitive pressure (30/100), brand roles are likely smaller and focused on cost management and defensive positioning.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on CYSTOGRAFIN DILUTE offers limited growth trajectory and requires focus on lifecycle management and cost-competitive positioning in a mature diagnostic space. Career development here involves defending market position and optimizing profitability rather than driving innovation or expansion.
Worked on CYSTOGRAFIN DILUTE at Bracco? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.